MedTrace Logo

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

NCT00329758 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-06-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of moderate head injury by improving amnesia and orientation.

Conditions

  • Head Injury

Interventions

DRUG

rosuvastatin

20 mg oral, during 10 days

DRUG

Placebo

Sponsors & Collaborators

  • Hospital Central "Dr. Ignacio Morones Prieto"

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Universidad Autonoma de San Luis Potosí

    lead OTHER

Principal Investigators

  • Jaime Torres-Corzo, Neurosurgeon · Hospital Central "Dr. Ignacio Morones Prieto"

  • Humberto Tapia-Perez, MD · Facultad de Medicina UASLP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00329758 on ClinicalTrials.gov